Get the Stockscreener App
1.98
7.91%
-0.17
After Hours:
2.00
0.02
+1.01%
Alector Inc stock is traded at $1.98, with a volume of 1.10M.
It is down -7.91% in the last 24 hours and up +8.79% over the past month.
Alector Inc is a clinical-stage biopharmaceutical company. It is engaged in developing a novel therapeutic approach for the treatment of neurodegeneration. The firm is involved in developing therapies that are designed to simultaneously counteract pathologies by restoring healthy immune function to the brain. Its pipeline products include AL001, AL002, AL003, and AL101.
See More
Previous Close:
$2.15
Open:
$2.15
24h Volume:
1.10M
Relative Volume:
0.96
Market Cap:
$216.12M
Revenue:
$100.56M
Net Income/Loss:
$-119.05M
P/E Ratio:
-1.6098
EPS:
-1.23
Net Cash Flow:
$-231.16M
1W Performance:
-22.66%
1M Performance:
+8.79%
6M Performance:
-34.22%
1Y Performance:
+27.74%
1-Day Range:
$1.935
$2.15
1-Week Range:
$1.935
$2.5286
52-Week Range:
$0.87
$3.3999
Alector Inc Stock (ALEC) Company Profile
Name
Alector Inc
Sector
Industry
Phone
415-231-5660
Address
131 OYSTER POINT BLVD., SUITE 600, SOUTH SAN FRANCISCO
Compare ALEC vs VRTX, REGN, ARGX, ALNY, ONC
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ALEC
Alector Inc
|
1.98 | 234.68M | 100.56M | -119.05M | -231.16M | -1.23 |
|
VRTX
Vertex Pharmaceuticals Inc
|
460.82 | 121.40B | 12.07B | 3.95B | 3.19B | 15.33 |
|
REGN
Regeneron Pharmaceuticals Inc
|
764.93 | 83.25B | 14.34B | 4.50B | 3.77B | 41.56 |
|
ARGX
Argen X Se Adr
|
728.11 | 46.39B | 4.16B | 1.29B | 734.26M | 19.59 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
320.51 | 43.41B | 3.71B | 313.75M | 465.38M | 2.2571 |
|
ONC
Beone Medicines Ltd Adr
|
292.94 | 33.09B | 5.36B | 287.73M | 924.18M | 2.5229 |
Alector Inc Stock (ALEC) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Oct-22-25 | Downgrade | BTIG Research | Buy → Neutral |
| Oct-22-25 | Downgrade | Cantor Fitzgerald | Overweight → Neutral |
| Oct-22-25 | Downgrade | Mizuho | Outperform → Neutral |
| Oct-22-25 | Downgrade | TD Cowen | Buy → Hold |
| Oct-22-25 | Downgrade | William Blair | Outperform → Mkt Perform |
| Jul-28-25 | Upgrade | Mizuho | Neutral → Outperform |
| Dec-17-24 | Downgrade | Mizuho | Outperform → Neutral |
| Dec-16-24 | Downgrade | Stifel | Buy → Hold |
| Dec-04-24 | Downgrade | BofA Securities | Neutral → Underperform |
| Nov-29-24 | Reiterated | H.C. Wainwright | Buy |
| Nov-26-24 | Downgrade | Morgan Stanley | Equal-Weight → Underweight |
| Dec-14-23 | Upgrade | Stifel | Hold → Buy |
| Dec-12-23 | Initiated | Deutsche Bank | Buy |
| Sep-25-23 | Initiated | Goldman | Sell |
| Sep-22-23 | Initiated | Cantor Fitzgerald | Overweight |
| Jan-06-23 | Downgrade | BofA Securities | Buy → Neutral |
| Sep-09-22 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Jul-07-22 | Initiated | Mizuho | Buy |
| Apr-13-22 | Initiated | Goldman | Sell |
| Mar-08-22 | Downgrade | Stifel | Buy → Hold |
| Sep-27-21 | Initiated | William Blair | Outperform |
| Jan-15-21 | Resumed | BofA Securities | Buy |
| Jun-24-20 | Initiated | H.C. Wainwright | Buy |
| Apr-28-20 | Initiated | Goldman | Buy |
| Mar-06-20 | Initiated | Citigroup | Buy |
| Feb-27-20 | Initiated | Barclays | Overweight |
| Feb-19-20 | Initiated | Stifel | Buy |
| Nov-21-19 | Initiated | BTIG Research | Buy |
| Mar-04-19 | Initiated | Barclays | Overweight |
| Mar-04-19 | Initiated | BofA/Merrill | Buy |
| Mar-04-19 | Initiated | Morgan Stanley | Overweight |
| Mar-04-19 | Initiated | SVB Leerink | Outperform |
View All
Alector Inc Stock (ALEC) Latest News
How The Alector (ALEC) Story Is Shifting As Analyst Targets And Sector Views Evolve - Yahoo Finance
Alector Showcases ABC Brain-Delivery Platform, AL137 and AL050 Updates at TD Cowen Conference - Yahoo Finance
Insider Sell: Grace Wong-sarad Sells Shares of Alector Inc (ALEC) - GuruFocus
Alector at TD Cowen Conference: Advancing Brain Therapeutics - Investing.com Nigeria
Alector (ALEC) accounting chief sells 3,367 shares under 10b5-1 plan - Stock Titan
Alector (ALEC) accounting officer sells shares to cover RSU tax bill - Stock Titan
RSU tax sale: Alector (NASDAQ: ALEC) CEO sells 81,864 shares - Stock Titan
Alector (ALEC) CFO sells 29,649 shares to cover RSU tax obligations - Stock Titan
HC Wainwright Estimates Alector FY2030 Earnings - MarketBeat
ALEC Earning Date, Earning Analysis and Earning Prediction - Intellectia AI
Alector (NASDAQ:ALEC) Stock Rating Lowered by Wall Street Zen - MarketBeat
Neil Berkley sale 37,261 shares; ALEC (NASDAQ: ALEC) RSUs vest 45,520 - Stock Titan
Insider Sell Alert: Grace Wong-sarad Sells Shares of Alector Inc (ALEC) - GuruFocus
Alector (NASDAQ:ALEC) Insider Grace Wong-Sarad Sells 4,079 Shares - MarketBeat
Alector (ALEC) accounting chief sells 4,079 shares via 10b5-1 plan - Stock Titan
[144] Alector, Inc. SEC Filing - Stock Titan
ALEC SEC FilingsAlector 10-K, 10-Q, 8-K Forms - Stock Titan
Alector (ALEC) Reports Q4 Loss, Beats Revenue Estimates - Yahoo Finance
Alector (NASDAQ:ALEC) Announces Earnings Results, Beats Expectations By $0.05 EPS - MarketBeat
Alector Inc reports results for the quarter ended September 30Earnings Summary - TradingView
Alector : February 2026 Corporate Presentation - marketscreener.com
Alector: Q4 Earnings Snapshot - marketscreener.com
Alector, Inc. Reports Earnings Results for the Full Year Ended December 31, 2025 - marketscreener.com
Alector (Nasdaq: ALEC) 2025 revenue drops as R&D falls and cash tops $256M - Stock Titan
Alector Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update - marketscreener.com
Investors Purchase High Volume of Alector Call Options (NASDAQ:ALEC) - MarketBeat
Alector (ALEC) Stock Analysis Report | Ratings, Financials & Performance - Benzinga España
Alector to Participate in the TD Cowen 46th Annual Health Care Conference - Bitget
Biotech Alector to stream TD Cowen health conference talk live online - Stock Titan
Alector (NASDAQ:ALEC) Stock Rating Upgraded by Wall Street Zen - MarketBeat
Alector Inc expected to post a loss of 38 cents a shareEarnings Preview - TradingView
Alector, Inc. (NASDAQ:ALEC) Receives Average Recommendation of "Hold" from Brokerages - MarketBeat
Alector (ALEC) to Release Earnings on Wednesday - MarketBeat
What The New Sector Driven Price Target Means For Alector's Story And Valuation - Yahoo Finance
Why Alector Inc. stock could outperform in 2025CEO Change & AI Driven Stock Price Forecasts - mfd.ru
Alector (NASDAQ: ALEC) holder RTW cuts ownership to 0% stake - Stock Titan
Is Alector Inc. stock a top pick in earnings seasonQuarterly Trade Report & Real-Time Chart Pattern Alerts - mfd.ru
What is Alector Inc.’s TAM (Total Addressable Market)Entry Point & AI Based Buy and Sell Signals - mfd.ru
What’s Alector Inc.’s historical returnJuly 2025 Sentiment & Capital Efficient Trading Techniques - mfd.ru
ALEC PE Ratio & Valuation, Is ALEC Overvalued - Intellectia AI
ALEC Should I Buy - Intellectia AI
Why Alector Inc. stock is a must watch in 20252025 Geopolitical Influence & Reliable Intraday Trade Plans - mfd.ru
Should I add Alector Inc. stock to my portfolioJuly 2025 Selloffs & Weekly Setup with ROI Potential - mfd.ru
Trade Recap: Does FANG stock reflect fundamentalsWeekly Trade Report & Weekly Momentum Picks - baoquankhu1.vn
Can Alector Inc. outperform under higher oil pricesTrade Ideas & Real-Time Market Sentiment Reports - mfd.ru
How The Narrative Around Alector (ALEC) Is Shifting After Index Removal And New Targets - Yahoo Finance
Aug Technicals: Is Alector Inc a cyclical or defensive stockWeekly Stock Recap & Free Risk Controlled Daily Trade Plans - baoquankhu1.vn
Legal Scrutiny Adds to Alector’s Clinical Setback Challenges - AD HOC NEWS
Panic Selling: Is NEXGEL Inc Equity Warrant benefiting from innovation trends2025 Technical Overview & Target Return Focused Picks - baoquankhu1.vn
INVESTOR ALERT: Levi & Korsinsky is Investigating Alec Stock After its Phase 3 INFRONT-3 Clinical Trial Misses Co-Primary Endpoint - Sahm
Levi & Korsinsky is Investigating Alec Stock After its Phase 3 INFRONT-3 Clinical Trial Misses Co-Primary Endpoint - marketscreener.com
Alector Inc Stock (ALEC) Financials Data
Revenue
Net Income
Cash Flow
EPS
3.69%
0.68%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):